These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25944999)

  • 1. Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma.
    Han KQ; He XQ; Ma MY; Guo XD; Zhang XM; Chen J; Han H; Zhang WW; Zhu QG; Nian H; Ma LJ
    World J Gastroenterol; 2015 Apr; 21(16):4864-74. PubMed ID: 25944999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine CXCL1 may serve as a potential molecular target for hepatocellular carcinoma.
    Han KQ; Han H; He XQ; Wang L; Guo XD; Zhang XM; Chen J; Zhu QG; Nian H; Zhai XF; Jiang MW
    Cancer Med; 2016 Oct; 5(10):2861-2871. PubMed ID: 27682863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice.
    Huang W; Chen Z; Zhang L; Tian D; Wang D; Fan D; Wu K; Xia L
    Gastroenterology; 2015 Oct; 149(4):1053-67.e14. PubMed ID: 26065367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted silencing of CXCL1 by siRNA inhibits tumor growth and apoptosis in hepatocellular carcinoma.
    Han KQ; He XQ; Ma MY; Guo XD; Zhang XM; Chen J; Han H; Zhang WW; Zhu QG; Zhao WZ
    Int J Oncol; 2015 Dec; 47(6):2131-40. PubMed ID: 26499374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway.
    Zhao J; Dong QZ; Zhong F; Cai LL; Qin ZY; Liu Y; Lin CZ; Qin LX; He FC
    Oncotarget; 2017 Feb; 8(7):12174-12185. PubMed ID: 28077802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.
    Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J
    J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes.
    Hirano S; Iwashita Y; Sasaki A; Kai S; Ohta M; Kitano S
    J Gastroenterol Hepatol; 2007 May; 22(5):690-6. PubMed ID: 17444857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinicopathological significance of miR-149 and PARP-2 in hepatocellular carcinoma and their roles in chemo/radiotherapy.
    Lin L; Zhang YD; Chen ZY; Chen Y; Ren CP
    Tumour Biol; 2016 Sep; 37(9):12339-12346. PubMed ID: 27300349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subsets of myeloid-derived suppressor cells in hepatocellular carcinoma express chemokines and chemokine receptors differentially.
    Zhao W; Xu Y; Xu J; Wu D; Zhao B; Yin Z; Wang X
    Int Immunopharmacol; 2015 Jun; 26(2):314-21. PubMed ID: 25891236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor-1α/interleukin-1β signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment.
    Zhang J; Zhang Q; Lou Y; Fu Q; Chen Q; Wei T; Yang J; Tang J; Wang J; Chen Y; Zhang X; Zhang J; Bai X; Liang T
    Hepatology; 2018 May; 67(5):1872-1889. PubMed ID: 29171040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo.
    Peng R; Zhao GX; Li J; Zhang Y; Shen XZ; Wang JY; Sun JY
    World J Gastroenterol; 2016 Mar; 22(12):3341-54. PubMed ID: 27022216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.
    Liu WR; Tian MX; Yang LX; Lin YL; Jin L; Ding ZB; Shen YH; Peng YF; Gao DM; Zhou J; Qiu SJ; Dai Z; He R; Fan J; Shi YH
    Oncotarget; 2015 Jan; 6(2):846-61. PubMed ID: 25514599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and modulation of Na(+) /H(+) exchanger 1 gene in hepatocellular carcinoma: A potential therapeutic target.
    Yang X; Wang D; Dong W; Song Z; Dou K
    J Gastroenterol Hepatol; 2011 Feb; 26(2):364-70. PubMed ID: 21261728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.
    Wei Y; Lao XM; Xiao X; Wang XY; Wu ZJ; Zeng QH; Wu CY; Wu RQ; Chen ZX; Zheng L; Li B; Kuang DM
    Gastroenterology; 2019 May; 156(6):1890-1904.e16. PubMed ID: 30711627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetyl-CoA metabolic accumulation promotes hepatocellular carcinoma metastasis via enhancing CXCL1-dependent infiltration of tumor-associated neutrophils.
    Pan JJ; Xie SZ; Zheng X; Xu JF; Xu H; Yin RQ; Luo YL; Shen L; Chen ZR; Chen YR; Yu SZ; Lu L; Zhu WW; Lu M; Qin LX
    Cancer Lett; 2024 Jun; 592():216903. PubMed ID: 38670307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.
    Jia XH; Feng GW; Wang ZL; Du Y; Shen C; Hui H; Peng D; Li ZJ; Kong DL; Tian J
    Oncotarget; 2016 Apr; 7(15):20934-44. PubMed ID: 26988913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stanniocalcin-1 Reduces Tumor Size in Human Hepatocellular Carcinoma.
    Yeung BH; Shek FH; Lee NP; Wong CK
    PLoS One; 2015; 10(10):e0139977. PubMed ID: 26469082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIF18B as a regulator in tumor microenvironment accelerates tumor progression and triggers poor outcome in hepatocellular carcinoma.
    Qiu MJ; Zhang L; Chen YB; Zhu LS; Zhang B; Li QT; Yang SL; Xiong ZF
    Int J Biochem Cell Biol; 2021 Aug; 137():106037. PubMed ID: 34217812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRT4 silencing in tumor-associated macrophages promotes HCC development via PPARδ signalling-mediated alternative activation of macrophages.
    Li Z; Li H; Zhao ZB; Zhu W; Feng PP; Zhu XW; Gong JP
    J Exp Clin Cancer Res; 2019 Nov; 38(1):469. PubMed ID: 31744516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The herbal compound Songyou Yin (SYY) inhibits hepatocellular carcinoma growth and improves survival in models of chronic fibrosis via paracrine inhibition of activated hepatic stellate cells.
    Bu Y; Jia QA; Ren ZG; Xue TC; Zhang QB; Zhang KZ; Zhang QB; You Y; Tian H; Qin LX; Tang ZY
    Oncotarget; 2015 Nov; 6(37):40068-80. PubMed ID: 26517671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.